PON1 and metabolic dysfunction-associated steatotic liver disease: Both PON1 and PON3 have also been found to be reduced in patients with MASLD in prior reports[8,9], and PON3 was even reduced in isolated high-density lipoprotein (HDL) lipoproteins from patients with MASLD[15].